State Street’s Biofrontera BFRI Stock Holding History

State Street’s Portfolio BFRI Stock Details BFRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,145	Closed	-$11.9K	–	4562
2023 Q2	$11.9K	Hold	1,145	–	–	﹤0.01%	4636
2023 Q1	$14K	Hold	1,145	–	–	﹤0.01%	4722
2022 Q4	$21K	Hold	1,145	–	–	﹤0.01%	4725
2022 Q3	$24K	Hold	1,145	–	–	﹤0.01%	4796
2022 Q2	$43K	Buy	1,145 +410	+56%	+$24.9K	﹤0.01%	4748
2022 Q1	$49K	Buy	+735	New	+$53.3K	﹤0.01%	4797

Other funds holding BFRI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

CSPIA

Cary Street Partners Investment Advisory Richmond, Virginia $494M AUM 27.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street's BFRI Position: Q3 2023 in Review

State Street sold out of Biofrontera (BFRI) in Q3 2023, closing a stake of 1,145 shares — an estimated $11.9K sold.

State Street first reported a position in BFRI in Q1 2022 and held it in 6 quarters. The position peaked at $49K in Q1 2022. 8 funds tracked by Wall St. Rank hold BFRI as of Q3 2023.

State Street reported no remaining Biofrontera position as of Q3 2023 after selling out during the quarter.
State Street sold 1,145 Biofrontera shares in Q3 2023, an estimated $11.9K.
State Street first reported a position in Biofrontera in Q1 2022 and held it in 6 quarters.
State Street's Biofrontera position peaked at $49K in Q1 2022.
8 funds tracked by Wall St. Rank held Biofrontera as of Q3 2023.

Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.